Article
MYB-fusions and other potential actionable targets in adenoid cystic carcinoma.
Current opinion in oncology - 1 May 2016
Ferrarotto Renata, Heymach John V, Glisson Bonnie S
Abstract excerpt
PURPOSE OF REVIEW: Adenoid cystic carcinoma (ACC) is a rare cancer of the secretory glands, typically originating in the salivary glands of the head and neck. The impact of chemotherapy on survival is unclear and there are no standard-of-care treatments for patients with recurrent or metastatic disease. This article reviews recently completed and ongoing clinical trials for patients with ACC and describes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
